General methods
All the starting materials were obtained from Sigma or Sangon Biotech. Commercially available reagents were used without further purification, unless noted otherwise. All chemicals were reagent grade or better.
1 H NMR and 13 C NMR spectra were obtained on a Bruker AV 300. Matrix-assisted laser desorption (MALDI) ionization-time of flight (TOF)/TOF and ESI mass spectra were obtained on a time-of-flight
Ultrflex II mass spectrometer (Bruker Daltonics) and on a Finnigan LCQ Advantage ion trap mass spectrometer (ThermoFisher Corporation) equipped with a standard ESI source, respectively. High performance liquid chromatography (HPLC) purification was performed on a Shimazu UFLC system equipped with two LC-20AP pumps and an SPD-20A UV/vis detector using a Shimazu PRC-ODS column.
HPLC analyses were performed on an Agilent 1200 system equipped with a G1322A pump and in-line diode array UV detector an Agilent Zorbax 300SD-C 18 RP column, with CH 3 CN (0.1% of TFA) and water (0.1% of TFA) as the eluent. Fluorescence spectra were recorded on an F-4600 fluorescence spectrophotometer (Hitachi High-Techonologies Corporation, Japan) with excitation wavelength set to 320 nm. UV-vis absorption spectra were recorded on a Pekin-Elmer lambda 25 spectrophotometer. Dynamic light scattering (DLS) was measured on a Zeta Sizer Nano Series (Malvern Instruments). Transmission electron micrograph (TEM) images were obtained on a JEM-2100F field emission transmission electron microscope operated at an acceleration voltage of 200 kV. Cell images were obtained on the IX71
fluorescence microscope (Olympus, Japan).
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General produce for enzymatic assay DMSO stock solutions of 1, 1-Scr, or 1-Ctrl were diluted with furin working buffer (100 mM HEPES, 1 mM CaCl 2 , pH = 7.4) to a final concentration of 100 μM working solutions, respectively. Next, 1 mM of tris(2-carboxyethyl)-phosphine (TCEP) and 1 nmol U -1 furin were added. The reaction mixtures were incubated at room temperature (RT) for 4 h and then their fluorescence spectra were measured. Each solution was excited at 320 nm, and the emission was collected from 340 to 620 nm.
Cell culture
MDA-MB-468 human breast adenocarcinoma epithelial cells were cultured in Dulbecco's modified eagle medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum (FBS, GIBCO) and streptomycin (100 μg/mL). The cells were expanded in tissue culture dishes and kept in a humid atmosphere of 5% CO 2 at 37 °C. The medium was changed every other day. The  cytotoxicity  of  MDA-MB-468  cells  was  measured  with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells growing in log phase were seeded into 96-well cell culture plate at 3 × 10 3 /well. The cells were incubated for 12 h at 37 °C under 5% CO 2 . The solutions of 1, 1-Scr, or 1-Ctrl (100 μL/well) at concentrations of 5, 10, 20, or 40 μM in 100 μL of medium were added to the wells, respectively. The cells were incubated for 2, 4, or, 8 h at 37 °C under 5% CO 2 . 10 μL solution of 5 mg/mL MTT dissolved in PBS buffer (pH 7.4) was added to each well of the 96-well plate. Then 100 μL solution DMSO was added to each well to dissolve the formazan after an additional 4 h of incubation. The data were obtained using an enzyme-linked S4 immunosorbent assay (ELISA) reader (VARIOSKAN FLASH) to detect its absorption at 490 nm. The following formula was used to calculate the viability of cell growth: viability (%) = (mean of absorbance value of treatment group/mean of absorbance value of control) × 100.
MTT assay

Time course cell imaging
The MDA-MB-468 human breast adenocarcinoma epithelial cells were plated on 3.5 cm cell culture dish at 50% cell density in the next day. Then the MDA-MB-468 cells were washed for three times with PBS and incubated with 5 μM 1 and 50 μM C in serum-free medium at 37 °C in a CO 2 incubator. The fluorescence images at DAPI channel were acquired every 10 min on the IX71 fluorescence microscope.
Sensing furin activity in living cells
The MDA-MB-468 human breast adenocarcinoma epithelial cells were plated on 3.5 cm cell culture dish at 50% cell density in the next day. Then the MDA-MB-468 cells were washed for three times with PBS and co-incubated 5 μM 1, 1-Scr, or 1-Ctrl with 50 μM C in serum-free medium at 37 °C for 1 h in a CO 2 incubator, respectively. Then, the cells were washed with PBS for another three times prior to microscopic imaging. For the furin-inhibiting group, MDA-MB-468 cells were pretreated with furin inhibitor II (H-(D)Arg-Arg-Arg-Arg-Arg-Arg-NH 2 , 500 μM) for 30 min in serum-free medium at 37 °C, washed with PBS for three times, then incubated with 5 μM 1 (co-incubated with 50 μM C) in serum-free medium at 37 °C for 1 h, and washed with PBS for another three times prior to microscopic imaging. Fluorescence intensities of the images from DAPI channel were analyzed with ImageJ (Universal Imaging Corp.).
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Chemical syntheses and characterizations of TPE-COOH, 1, 1-Scr and 1-Ctrl
Preparation of TPE-COOH.
4-(1,2,2-Triphenylvinyl)benzoic acid (TPE-COOH) was synthesized following the literature method.
1 Scheme S1. The synthetic route for TPE-COOH.
Synthesis of 1-(4-Bromophenyl)-1,2,2-triphenylethene (TPE-Br):
TPE-Br was synthesized according to the synthetic route shown in Scheme S1. The procedures for its synthesis are shown as follows. To a solution of diphenylmethane (2.9 g; 17.5 mmol) in dry tetrahydrofuran (50 mL) was added dropwise 11 mL of a 1.6 M solution of n-butyllithium in hexane (17.5 mmol) at 0 °C under nitrogen. The resulting orange-red solution was further stirred for 1 h. Then 4-bromobenzophenone (3.8 g, 14.6 mmol) was added into this solution. Afterwards, the reaction mixture was allowed to warm to RT and stirred overnight. 
Synthesis of 4-(1,2,2-Triphenylvinyl)benzoic acid (TPE-COOH):
To a solution of TPE-Br (2.2 g, 5.35 mmol) in 30 mL dry THF was added dropwise 4 mL (6.42 mmol) of n-butyllithium (1.6 M in n-hexane) at -78 °C under stirring. The reaction mixture was stirred for 2 h to get a dark brown solution. Then dry ice pieces in small portions were slowly added to the obtained solution at -78 °C under stirring. The solution was allowed to warm to RT and stir overnight. The resulting solution was acidified with an excess amount of 1 M hydrochloric acid and extracted with DCM several times. The organic layer was combined and dried over anhydrous Na 2 SO 4 . The organic solvent was removed under reduced pressure. The crude product was obtained by recrystallization. TPE-COOH was further purified with HPLC using water-acetonitrile added with 0.1% TFA as the eluent. Yield: 68%. Scheme S2. The synthetic route for 1.
Synthesis of B:
Compound Figure   S5 ).
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Preparation of Ac-Arg-Lys(TPE)-Arg-Cys(StBu)-Arg-Val-CBT (1-Scr):
Scheme S3. The synthetic route for 1-Scr.
Synthesis of 1-Scr:
Compound D was synthesized with solid phase peptide synthesis (SPPS). Then coupled to CBT with the same method as above, followed by labeling with TPE-NHS ester in DMF overnight at RT. Compound 1-Scr (20 mg, yield 60%) was obtained after HPLC purification using water-acetonitrile added with 0.1%
TFA as the eluent. Figure S8 ).
Preparation of Ac-Arg-Val-Arg-Arg-Lys(TPE)-OH (1-Ctrl):
Scheme S4. The synthetic route for 1-Ctrl.
Synthesis of 1-Ctrl:
Compound G was synthesized with solid phase peptide synthesis (SPPS). Then the Boc and Pbf protecting groups of compound G were removed with dichloromethane (DCM, 300 μL) and triisopropylsilane (TIPS, 200 μL) in TFA (9.5 mL) for 3 h. Figure S11 ). 
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(co-incubated with 50 μM C) for 1 h, washed with PBS for another three times prior to imaging, respectively. All images have the same scale bar: 10 μm. Table S1 . HPLC condition for the purifications of 1, 1-Scr, and 1-Ctrl. Table S2 . HPLC condition for the enzymatic assay of 1 and 1-Scr in Fig. 2D and S15. 
